Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.

Saved in:
Bibliographic Details
Title: Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.
Authors: Solini A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Simeon V; Laboratory of Pre-Clinical and Translational Research, IRCCS - CROB Referral Cancer Center of Basilicata, Rionero in Vulture, Potenza, Italy., Derosa L; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy., Orlandi P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Rossi C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Fontana A; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy., Galli L; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy., Di Desidero T; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Fioravanti A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Lucchesi S; Division of Medical Oncology, Pontedera Hospital, Azienda USL of Pisa, Pontedera, Italy., Coltelli L; Division of Medical Oncology, Pontedera Hospital, Azienda USL of Pisa, Pontedera, Italy., Ginocchi L; Division of Medical Oncology, Pontedera Hospital, Azienda USL of Pisa, Pontedera, Italy., Allegrini G; Division of Medical Oncology, Pontedera Hospital, Azienda USL of Pisa, Pontedera, Italy., Danesi R; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Falcone A; Oncology Unit 2, University Hospital of Pisa, Pisa, Italy., Bocci G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Source: Oncotarget [Oncotarget] 2015 Oct 06; Vol. 6 (30), pp. 28743-54.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.4926